MSD acquires WuXi Vaccines' Dundalk facility with a €500 million investment, creating 1,000 new jobs across Ireland and ...

The transaction is expected to close in the first half of 2025, subject to the satisfaction of customary closing conditions.

Nov. 20, 2024 — Wings may be the obvious choice when studying the connection between dinosaurs and birds, but a pair of paleontologists prefer drumsticks. That part of the leg, they say, is ...

MSD has spent €500M acquiring a Dundalk vaccine plant and several other facilities around Ireland in an early year boost for ...

China's WuXi Biologics has confirmed it will sell its vaccine facility in Ireland to US drugmaker Merck & Co for about €500 ...

Pharmaceutical firm MSD has agreed a deal to buy the WuXi Vaccines manufacturing facility in Dundalk, Co Louth as part of its ...

The acquisition from Wuxi Biologics, the embattled CDMO named in the BIOSECURE Act, marks another expansion of Merck’s ...

News that pharmaceutical company MSD Ireland has acquired the WuXi Vaccines manufacturing facility in Dundalk has been ...

In Ireland, WuXi Biologics has sold a new vaccines plant to Merck & Co. for €500 million ($521 million). The New Jersey ...

Winter Storm Blair hits the Northeast and Mid-Atlantic US with snow and freezing temperatures.

MSD has expanded its presence in Ireland with an agreement to buy a vaccine manufacturing facility from Chinese biotech WuXi ...

US multinational pharmaceutical company MSD has today (6 January) announced the acquisition of WuXi Vaccines’ Dundalk site.